Vanda Pharmaceuticals Inc.·4

Feb 24, 7:04 PM ET

Moran Kevin Patrick 4

4 · Vanda Pharmaceuticals Inc. · Filed Feb 24, 2025

Insider Transaction Report

Form 4
Period: 2025-02-21
Moran Kevin Patrick
SVP, CFO & Treasurer
Transactions
  • Purchase

    Common Stock

    2025-02-21$4.39/sh+2,000$8,779355,763 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    635

Documents

1 file
  • 4
    ownership.xmlPrimary

    4